[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 404
Citations 0
In This Issue of JAMA Internal Medicine
February 2020


JAMA Intern Med. 2020;180(2):173-175. doi:10.1001/jamainternmed.2019.4351

In this cluster randomized clinical trial, Romskaug and colleagues investigated the effect of clinical geriatric assessments and collaborative medication reviews by geriatricians and family physicians on health-related quality of life and other patient-relevant outcomes in home-dwelling older patients receiving polypharmacy. The study intervention consisted of clinical geriatric assessment of the patients combined with a thorough review of their medications, a meeting between the geriatrician and the family physician, and clinical follow-up. Results showed that health-related quality of life at follow-up at 16 weeks was statistically significantly better in patients who received the intervention compared with those who received usual care.